Breast cancer is the most diagnosed cancer amongst women (2.1 million cases each year) accounting for almost 1 in 4 cancer cases.
Metastatic Breast Cancer (MBC) is the most advanced stage of breast cancer and occurs when the disease spreads to other parts of the body such as lungs, brain, liver and bones.
To tackle this growing cancer burden UICC launched the Seeding Progress and Resources for the Cancer Community (SPARC) Metastatic Breast Cancer (MBC) Challenge in 2015. A grants programme, delivered in partnership with Pfizer.
This initiative aims to empower advocacy groups, hospital networks and other non-for-profit organisations addressing the specific needs of MBC patients worldwide. SPARC supports the launch of new projects aiming at supporting MBC patients as well as reducing the number of women diagnosed at an advanced stage of breast cancer. SPARC projects aim at reducing the patient information and support gap, growing awareness around the disease, influencing national policies and strengthening health systems. To date, 40 organisations in 30 countries have benefited from the SPARC MBC Challenge.
In 2019, ten additional organisations will be selected to receive a SPARC grant, bringing the SPARC network to a total of 50 organisations. Read the official press release about the launch of the 3rd round of SPARC grants here
UICC and Pfizer support these organisations to deliver effective and impactful projects by proving them with seed-funding, training, access to international events on MBC, mentorship and peer-to-peer learning.
Financial support to start new projects
Since 2015, SPARC has enabled more than 14’000 MBC patients to benefit from patient support groups, psychosocial interventions and navigation programmes. Over 140’000 people have been reached by MBC informational resources and awareness campaigns, and 2’300 professionals have been trained on palliative care, advocacy for MBC and patient navigation.
In 2015, 20 competitively selected organisations were supported to implement novel and sustainable projects addressing the unique challenges facing women with metastatic breast cancer in their country. In 2017, another 20 projects benefitted from a new round of grants. The 2019 cohort is being selected and the new SPARC grantees will be announced in October 2019.
The SPARC Metastatic Breast Cancer (MBC) Challenge is a UICC grants programme, delivered in partnership with Pfizer.